TMCI - TREACE MEDICAL CONCEPTS, INC.
IEX Last Trade
6.93
0.020 0.289%
Share volume: 6,848
Last Updated: Fri 27 Dec 2024 08:30:19 PM CET
Surgical and Medical Instrument Manufacturing :
-0.06%
PREVIOUS CLOSE
CHG
CHG%
$6.91
0.02
0.29%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-10 | 2022-11-09 | 2023-03-08 | 2023-05-09 | 2023-08-09 | 2023-11-09 | 2024-02-27 | 2024-05-07 | |
| Assets | |||||||||
| Total Assets | 158.722 M | 156.443 M | 159.024 M | 249.170 M | 249.643 M | 240.360 M | 251.907 M | 242.726 M | |
| Current Assets | 135.197 M | 127.902 M | 133.402 M | 223.133 M | 198.096 M | 187.142 M | 198.359 M | 187.397 M | |
| Inventories | 13.168 M | 16.794 M | 19.330 M | 22.519 M | 26.101 M | 29.312 M | 29.245 M | 35.860 M | |
| Other Current Assets | 3.995 M | 4.014 M | 3.624 M | 4.587 M | 5.284 M | 10.671 M | 7.853 M | 11.448 M | |
| Short Term Investments | 3.995 M | 4.014 M | 3.624 M | 4.587 M | 5.284 M | 10.671 M | 7.853 M | 11.448 M | |
| Total Receivables | 16.501 M | 18.548 M | 29.196 M | 25.365 M | 27.232 M | 24.996 M | 38.063 M | 30.083 M | |
| Current Cash | 101.533 M | 88.546 M | 81.252 M | 170.662 M | 139.479 M | 122.163 M | 123.198 M | 110.006 M | |
| Total Non-current Assets | 23.525 M | 28.541 M | 25.622 M | 26.037 M | 51.547 M | 53.218 M | 53.548 M | 55.329 M | |
| Property Plant Equipment | 8.741 M | 14.148 M | 15.338 M | 15.915 M | 19.435 M | 21.536 M | 22.298 M | 24.517 M | |
| Other Assets | 14.784 M | 14.393 M | 10.284 M | 10.122 M | 9.797 M | 9.605 M | 9.410 M | 9.210 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 9.500 M | 9.262 M | 9.025 M | 8.787 M | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 12.815 M | 12.815 M | 12.815 M | 12.815 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 158.722 M | 156.443 M | 159.024 M | 249.170 M | 249.643 M | 240.360 M | 251.907 M | 242.726 M | |
| Total liabilities | 87.010 M | 94.242 M | 98.495 M | 91.553 M | 99.684 M | 102.500 M | 113.969 M | 116.335 M | |
| Total current liabilities | 16.637 M | 22.580 M | 30.245 M | 23.296 M | 30.022 M | 33.154 M | 45.033 M | 47.049 M | |
| Accounts Payable | 3.099 M | 7.881 M | 8.668 M | 5.076 M | 8.146 M | 8.680 M | 11.835 M | 21.149 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 25.000 K | 37.000 K | 37.000 K | 37.000 K | 37.000 K | |
| Current long term debt | 383.000 K | 330.000 K | 339.000 K | 1.058 M | 0.000 | 0.000 | 4.432 M | 0.000 | |
| Long term debt | 70.373 M | 71.662 M | 68.250 M | 68.232 M | 69.625 M | 69.309 M | 68.899 M | 69.249 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 25.000 K | 37.000 K | 37.000 K | 37.000 K | 37.000 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 71.712 M | 62.201 M | 60.529 M | 157.617 M | 149.959 M | 137.860 M | 137.938 M | 126.391 M | |
| Common stock | 55.308 M | 55.429 M | 55.542 M | 58.724 M | 61.383 M | 61.562 M | 61.740 M | 61.793 M | |
| Retained earnings | -68.175 M | -80.308 M | -84.720 M | -98.174 M | -110.445 M | -127.966 M | -134.247 M | -152.923 M |